
NYSE:VTR
This summary was created by AI, based on 3 opinions in the last 12 months.
Ventas Inc (VTR-N) is a leading player in the healthcare REIT sector, particularly known for its nursing and retirement homes. The company has been experiencing significant growth, highlighted by a consistent earnings growth rate of 10%, and a notable 2,177% increase in shares since 2000. With the lowest price-to-earnings (PE) ratio in its sector, it presents a compelling investment case. With the same CEO at the helm since 1999, the firm shows stability in its leadership. Although the stock is currently slightly overbought, experts suggest buying on dips to accumulate shares in this growth-centric domain of healthcare, especially in seniors housing, projected to continue thriving for years to come.
He likes the healthcare space, and this company owns medical office buildings, seniors’ homes, etc. This is generally a good business. However, being structured as a REIT, it has had a huge, huge run in share price and trades at a fairly steep valuation. It is vulnerable to interest rates coming down. He prefers Capital Senior Living (CSU-N) which trades at a much more modest valuation. Dividend yield of 4.2%.
A healthcare REIT. He owns a similar one. They are growth vehicles and trade significantly above NAV because they are constantly acquiring. The prices come off when there is a sign their acquisitions will drop off. They are looking at Canada. He thinks you are better buying companies they may want to acquire, however.
Seniors housing REIT in the US. He likes it. It has been clobbered. The decline is based on the broader US REIT index. People are getting older and you should see an increase in demand for seniors housing. You should see good rent increases. It is a little bit growth by acquisition based which is harder when you are trading at a discount.
Ventas Inc is a American stock, trading under the symbol VTR (previously VTR-N on Stockchase) on the New York Stock Exchange (VTR). It is usually referred to as NYSE:VTR or VTR
In the last year, 3 stock analysts published opinions about VTR (previously VTR-N on Stockchase). 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Ventas Inc.
Ventas Inc was recommended as a Top Pick by Derek Warren on 2014-06-13. Read the latest stock experts ratings for Ventas Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Ventas Inc in the last year. It is a trending stock that is worth watching.
On 2026-06-01, Ventas Inc (VTR) stock closed at a price of $81.71.
Nursing homes. 20x FFO and 10% earnings growth.